Previous Article | Next Article 
Journal of Virology, April 2003, p. 4449-4456, Vol. 77, No. 7
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.7.4449-4456.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C
Tonie Cilliers,1 Jabulani Nhlapo,1 Mia Coetzer,1 Dragana Orlovic,2 Thomas Ketas,3 William C. Olson,3 John P. Moore,4 Alexandra Trkola,5 and Lynn Morris1*
AIDS Virus Research Unit, National Institute for Communicable Diseases,1
Sizwe Infectious Diseases Hospital, Johannesburg, South Africa,2
Progenics Pharmaceuticals Inc., Tarrytown,3
Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York,4
Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich, Switzerland5
Received 3 September 2002/
Accepted 23 December 2002
Human immunodeficiency virus type 1 (HIV-1) subtype C viruses with different coreceptor usage profiles were isolated from 29 South African patients with advanced AIDS. All 24 R5 isolates were inhibited by the CCR5-specific agents, PRO 140 and RANTES, while the two X4 viruses and the three R5X4 viruses were sensitive to the CXCR4-specific inhibitor, AMD3100. The five X4 or R5X4 viruses were all able to replicate in peripheral blood mononuclear cells that did not express CCR5. When tested using coreceptor-transfected cell lines, one R5 virus was also able to use CXCR6, and another R5X4 virus could use CCR3, BOB/GPR15, and CXCR6. The R5X4 and X4 viruses contained more-diverse V3 loop sequences, with a higher overall positive charge, than the R5 viruses. Hence, some HIV-1 subtype C viruses are able to use CCR5, CXCR4, or both CXCR4 and CCR5 for entry, and they are sensitive to specific inhibitors of entry via these coreceptors. These observations are relevant to understanding the rapid spread of HIV-1 subtype C in the developing world and to the design of intervention and treatment strategies.
* Corresponding author. Mailing address: AIDS Virus Research Unit, National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, Johannesburg, South Africa. Phone: 2711 321-4232. Fax: 2711 321-4234. E-mail:
lynnm{at}niv.ac.za.
Journal of Virology, April 2003, p. 4449-4456, Vol. 77, No. 7
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.7.4449-4456.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Isaacman-Beck, J., Hermann, E. A., Yi, Y., Ratcliffe, S. J., Mulenga, J., Allen, S., Hunter, E., Derdeyn, C. A., Collman, R. G.
(2009). Heterosexual Transmission of Human Immunodeficiency Virus Type 1 Subtype C: Macrophage Tropism, Alternative Coreceptor Use, and the Molecular Anatomy of CCR5 Utilization. J. Virol.
83: 8208-8220
[Abstract]
[Full Text]
-
Coetzer, M., Nedellec, R., Salkowitz, J., McLaughlin, S., Liu, Y., Heath, L., Mullins, J. I., Mosier, D. E.
(2008). Evolution of CCR5 Use before and during Coreceptor Switching. J. Virol.
82: 11758-11766
[Abstract]
[Full Text]
-
Taylor, B. S., Sobieszczyk, M. E., McCutchan, F. E., Hammer, S. M.
(2008). The Challenge of HIV-1 Subtype Diversity. NEJM
358: 1590-1602
[Full Text]
-
Patel, M. B., Hoffman, N. G., Swanstrom, R.
(2008). Subtype-Specific Conformational Differences within the V3 Region of Subtype B and Subtype C Human Immunodeficiency Virus Type 1 Env Proteins. J. Virol.
82: 903-916
[Abstract]
[Full Text]
-
Travers, S. A. A., Tully, D. C., McCormack, G. P., Fares, M. A.
(2007). A Study of the Coevolutionary Patterns Operating within the env Gene of the HIV-1 Group M Subtypes. Mol Biol Evol
24: 2787-2801
[Abstract]
[Full Text]
-
Pastore, C., Nedellec, R., Ramos, A., Hartley, O., Miamidian, J. L., Reeves, J. D., Mosier, D. E.
(2007). Conserved Changes in Envelope Function during Human Immunodeficiency Virus Type 1 Coreceptor Switching. J. Virol.
81: 8165-8179
[Abstract]
[Full Text]
-
Huang, W., Eshleman, S. H., Toma, J., Fransen, S., Stawiski, E., Paxinos, E. E., Whitcomb, J. M., Young, A. M., Donnell, D., Mmiro, F., Musoke, P., Guay, L. A., Jackson, J. B., Parkin, N. T., Petropoulos, C. J.
(2007). Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations. J. Virol.
81: 7885-7893
[Abstract]
[Full Text]
-
Li, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., Mlisana, K., Karim, S. A., Hong, K., Greene, K. M., Bilska, M., Zhou, J., Allen, S., Chomba, E., Mulenga, J., Vwalika, C., Gao, F., Zhang, M., Korber, B. T. M., Hunter, E., Hahn, B. H., Montefiori, D. C.
(2006). Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa. J. Virol.
80: 11776-11790
[Abstract]
[Full Text]
-
Jensen, M. A., Coetzer, M., van 't Wout, A. B., Morris, L., Mullins, J. I.
(2006). A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope v3 sequences.. J. Virol.
80: 4698-4704
[Abstract]
[Full Text]
-
Lauren, A., Vodros, D., Thorstensson, R., Fenyo, E. M.
(2006). Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome.. J. Gen. Virol.
87: 581-594
[Abstract]
[Full Text]
-
Rusert, P., Kuster, H., Joos, B., Misselwitz, B., Gujer, C., Leemann, C., Fischer, M., Stiegler, G., Katinger, H., Olson, W. C., Weber, R., Aceto, L., Gunthard, H. F., Trkola, A.
(2005). Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors. J. Virol.
79: 8454-8469
[Abstract]
[Full Text]
-
Brown, B. K., Darden, J. M., Tovanabutra, S., Oblander, T., Frost, J., Sanders-Buell, E., de Souza, M. S., Birx, D. L., McCutchan, F. E., Polonis, V. R.
(2005). Biologic and Genetic Characterization of a Panel of 60 Human Immunodeficiency Virus Type 1 Isolates, Representing Clades A, B, C, D, CRF01_AE, and CRF02_AG, for the Development and Assessment of Candidate Vaccines. J. Virol.
79: 6089-6101
[Abstract]
[Full Text]
-
Princen, K., Hatse, S., Vermeire, K., Aquaro, S., De Clercq, E., Gerlach, L.-O., Rosenkilde, M., Schwartz, T. W., Skerlj, R., Bridger, G., Schols, D.
(2004). Inhibition of Human Immunodeficiency Virus Replication by a Dual CCR5/CXCR4 Antagonist. J. Virol.
78: 12996-13006
[Abstract]
[Full Text]
-
Hoshino, Y., Tse, D. B., Rochford, G., Prabhakar, S., Hoshino, S., Chitkara, N., Kuwabara, K., Ching, E., Raju, B., Gold, J. A., Borkowsky, W., Rom, W. N., Pine, R., Weiden, M.
(2004). Mycobacterium tuberculosis-Induced CXCR4 and Chemokine Expression Leads to Preferential X4 HIV-1 Replication in Human Macrophages. J. Immunol.
172: 6251-6258
[Abstract]
[Full Text]
-
Pollakis, G., Abebe, A., Kliphuis, A., Chalaby, M. I. M., Bakker, M., Mengistu, Y., Brouwer, M., Goudsmit, J., Schuitemaker, H., Paxton, W. A.
(2004). Phenotypic and Genotypic Comparisons of CCR5- and CXCR4-Tropic Human Immunodeficiency Virus Type 1 Biological Clones Isolated from Subtype C-Infected Individuals. J. Virol.
78: 2841-2852
[Abstract]
[Full Text]
-
Johnston, E. R., Zijenah, L. S., Mutetwa, S., Kantor, R., Kittinunvorakoon, C., Katzenstein, D. A.
(2003). High Frequency of Syncytium-Inducing and CXCR4-Tropic Viruses among Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients Receiving Antiretroviral Treatment. J. Virol.
77: 7682-7688
[Abstract]
[Full Text]